AAAAAA

   
Results: 1-13 |
Results: 13

Authors: Harrington, IJ Sekyi-Otu, A Barrington, TW Evans, DC Tuli, V
Citation: Ij. Harrington et al., The functional outcome with metallic redial head implants in the treatmentof unstable elbow fractures: A long-term review, J TRAUMA, 50(1), 2001, pp. 46-52

Authors: Poon, GK Chen, Q Teffera, Y Ngui, JS Griffin, PR Braun, MP Doss, GA Freeden, C Stearns, RA Evans, DC Baillie, TA Tang, W
Citation: Gk. Poon et al., Bioactivation of diclofenac via benzoquinone imine intermediates-identification of urinary mercapturic acid derivatives in rats and humans, DRUG META D, 29(12), 2001, pp. 1608-1613

Authors: Renwick, AB Lewis, DFV Fulford, S Surry, D Williams, B Worboys, PD Cai, X Wang, RW Price, RJ Lake, BG Evans, DC
Citation: Ab. Renwick et al., Metabolism of 2,5-bis(trifluoromethyl)-7-benzyloxy-4-trifluoromethylcoumarin by human hepatic CYP isoforms: evidence for selectivity towards CYP3A4, XENOBIOTICA, 31(4), 2001, pp. 187-204

Authors: Watt, AP Morrison, D Evans, DC
Citation: Ap. Watt et al., Approaches to higher-throughput pharmacokinetics (HTPK) in drug discovery, DRUG DISC T, 5(1), 2000, pp. 17-24

Authors: Price, RJ Surry, D Renwick, AB Meneses-Lorente, G Lake, BG Evans, DC
Citation: Rj. Price et al., CYP isoform induction screening in 96-well plates: use of 7-benzyloxy-4-trifluoromethylcoumarin as a substrate for studies with rat hepatocytes, XENOBIOTICA, 30(8), 2000, pp. 781-795

Authors: Surry, DD Meneses-Lorente, G Heavens, R Jack, A Evans, DC
Citation: Dd. Surry et al., Rapid determination of rat hepatocyte mRNA induction potential using oligonucleotide probes for CYP1A1, 1A2, 3A and 4A1, XENOBIOTICA, 30(5), 2000, pp. 441-456

Authors: Renwick, AB Surry, D Price, RJ Lake, BG Evans, DC
Citation: Ab. Renwick et al., Metabolism of 7-benzyloxy-4-trifluoromethyl-coumarin by human hepatic cytochrome P450 isoforms, XENOBIOTICA, 30(10), 2000, pp. 955-969

Authors: Evans, DC
Citation: Dc. Evans, Vietnam nursing, MILIT MED, 165(12), 2000, pp. IV-IV

Authors: Rasmussen, K Calligaro, DO Czachura, JF Dreshfield-Ahmad, LJ Evans, DC Hemrick-Luecke, SK Kallman, MJ Kendrick, WT Leander, JD Nelson, DL Overshiner, CD Wainscott, DB Wolff, MC Wong, DT Branchek, TA Zgombick, JM Xu, YC
Citation: K. Rasmussen et al., The novel 5-hydroxytryptamine(1A) antagonist LY426965: effects on nicotinewithdrawal and interactions with fluoxetine, J PHARM EXP, 294(2), 2000, pp. 688-700

Authors: Watt, AP Morrison, D Locker, KL Evans, DC
Citation: Ap. Watt et al., Higher throughput bioanalysis by automation of a protein precipitation assay using a 96-well format with detection by LC-MS/MS, ANALYT CHEM, 72(5), 2000, pp. 979-984

Authors: van Niel, MB Beer, MS Castro, JL Cheng, SKF Evans, DC Heald, A Hitzel, L Hunt, P Mortishire-Smith, R O'Connor, D Watt, AP MacLeod, AM
Citation: Mb. Van Niel et al., Parallel synthesis of 3-aryloxy-2-propanolamines and evaluation as dual affinity 5-HT1A and 5-HT re-uptake ligands, BIOORG MED, 9(22), 1999, pp. 3243-3248

Authors: Surry, DD McAllister, G Meneses-Lorente, G Evans, DC
Citation: Dd. Surry et al., High throughput ribonuclease protection assay for the determination of CYP3A mRNA induction in cultured rat hepatocytes, XENOBIOTICA, 29(8), 1999, pp. 827-838

Authors: Lake, BG Renwick, AB Cunninghame, ME Price, RJ Surry, D Evans, DC
Citation: Bg. Lake et al., Comparison of the effects of some CYP3A and other enzyme inducers on replicative DNA synthesis and cytochrome P450 isoforms in rat liver, TOXICOLOGY, 131(1), 1998, pp. 9-20
Risultati: 1-13 |